Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inhaled Medications01:23

Inhaled Medications

Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
Asthma-IV: Nursing Management01:30

Asthma-IV: Nursing Management

The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Current state of electronic problems lists in primary care: a rapid scoping review.

Family practice·2026
Same author

Ensuring continued access to essential inhaled respiratory medications: a call to action from the Inhaled Respiratory medicine Innovation and environmental Sustainability (IRIS) group.

The European respiratory journal·2026
Same author

Effectiveness of FF/UMEC/VI versus ICS/LABA in Patients with Uncontrolled Asthma Treated in Routine Clinical Practice (PERFORM): A Pragmatic Randomized Controlled Trial.

Journal of asthma and allergy·2026
Same author

Understanding inhaler users' perceptions of climate change and inhaler carbon footprints: insights from a Canadian survey.

BMJ open respiratory research·2026
Same author

Induction of Labour: A Qualitative Study of the Patient Experience.

Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC·2026
Same author

Effectiveness of inpatient geriatric rehabilitation in those with cognitive impairment: a secondary analysis of meta-analysis data.

BMC geriatrics·2026
Same journal

How I Do It: De-escalation of Prostacyclin-Based Therapy in Patients Treated With Sotatercept.

Chest·2026
Same journal

Eisenmenger Syndrome: The Pulmonology Perspective.

Chest·2026
Same journal

Phenotyping of pulmonary arterial hypertension associated with congenital heart disease using latent class analysis: insights from a national prospective registry.

Chest·2026
Same journal

Septic Shock and GLP-1 Analogue Association in Real World - A Propensity Score Matched Analysis.

Chest·2026
Same journal

PREVALENCE AND RISK FACTORS OF PRESERVED RATIO IMPAIRED SPIROMETRY (PRISm) IN PEOPLE WITH HIV AND MATCHED POPULATION CONTROLS.

Chest·2026
Same journal

How I Do It: Counseling Patients About Outdoor Exercise During Air Pollution Events.

Chest·2026
See all related articles
  1. Home
  3. A Conversation Aid For Climate Conscious Inhaler Prescribing.
  1. Home
  3. A Conversation Aid For Climate Conscious Inhaler Prescribing.

Related Experiment Video

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
14:39

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 4, 2010

A Conversation Aid for Climate Conscious Inhaler Prescribing.

Stacey J Butler1, Tony Ning1, George Alexander Balaci1

  • 1Division of Respirology, St. Michael's Hospital, Unity Health Toronto, Toronto, Ontario, Canada.

Chest
|June 15, 2026

View abstract on PubMed

Summary
This summary is machine-generated.

Developing climate-conscious inhaler prescribing aids requires patient and physician input. Co-created tools enhance confidence in selecting low carbon footprint inhalers for asthma and COPD management.

Keywords:
AsthmaCOPDEnvironmentInhaler DevicesInhalersShared Decision-Making

More Related Videos

Inspiratory Muscle Training as an Adjunct to the Treatment of Weaning Failure in Critically Ill Patients: A Practical Guide
04:16

Inspiratory Muscle Training as an Adjunct to the Treatment of Weaning Failure in Critically Ill Patients: A Practical Guide

Published on: January 30, 2026

Evaluating Regional Pulmonary Deposition using Patient-Specific 3D Printed Lung Models
07:56

Evaluating Regional Pulmonary Deposition using Patient-Specific 3D Printed Lung Models

Published on: November 11, 2020

Related Experiment Videos

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
14:39

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 4, 2010

Inspiratory Muscle Training as an Adjunct to the Treatment of Weaning Failure in Critically Ill Patients: A Practical Guide
04:16

Inspiratory Muscle Training as an Adjunct to the Treatment of Weaning Failure in Critically Ill Patients: A Practical Guide

Published on: January 30, 2026

Evaluating Regional Pulmonary Deposition using Patient-Specific 3D Printed Lung Models
07:56

Evaluating Regional Pulmonary Deposition using Patient-Specific 3D Printed Lung Models

Published on: November 11, 2020

Area of Science:

  • Environmental medicine
  • Health informatics
  • Patient-centered care

Background:

  • Climate change necessitates reducing the carbon footprint of medical devices.
  • Inhalers, widely used for respiratory conditions, contribute significantly to greenhouse gas emissions.
  • Prescribing low carbon footprint inhalers requires balancing environmental impact with patient safety and preferences.

Purpose of the Study:

  • To determine the optimal content and design for inhaler conversation aids.
  • To facilitate climate-conscious prescribing for asthma and chronic obstructive pulmonary disease (COPD).

Main Methods:

  • Developed a web-based conversation aid prototype with tailored versions for different patient groups.
  • Employed iterative rapid-cycle development using interviews, focus groups, and surveys with patients and physicians.
  • Revised the tool based on feedback to optimize content and usability.

    • Main Results:

    • Recruited 25 patients and 5 family physicians over five development rounds.
    • Key revisions included simplifying language, clarifying cost and safety information, and addressing patient concerns about switching inhalers.
    • Patients and physicians highly rated the tool, indicating increased confidence in selecting low carbon footprint inhalers.

    Conclusions:

    • End-user engagement is crucial for developing effective shared decision-making tools.
    • Co-created conversation aids can support clinicians and patients in choosing environmentally sustainable inhaler options.
    • This approach fosters shared decision-making at the point-of-care for climate-conscious respiratory care.